Operating Lease, Right-of-Use Asset of Vistagen Therapeutics, Inc. from 31 Mar 2019 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Vistagen Therapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Mar 2019 to 31 Dec 2025.
  • Vistagen Therapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 31 Dec 2025 was $939,000, a 36% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Vistagen Therapeutics, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $939,000 -$522,000 -36% 31 Dec 2025 10-Q 12 Feb 2026 2026 Q3
Q3 2025 $1,074,000 -$509,000 -32% 30 Sep 2025 10-Q 13 Nov 2025 2026 Q2
Q2 2025 $1,206,000 -$497,000 -29% 30 Jun 2025 10-Q 07 Aug 2025 2026 Q1
Q1 2025 $1,335,000 -$485,000 -27% 31 Mar 2025 10-Q 12 Feb 2026 2026 Q3
Q4 2024 $1,461,000 -$472,600 -24% 31 Dec 2024 10-Q 13 Feb 2025 2025 Q3
Q3 2024 $1,583,000 -$462,000 -23% 30 Sep 2024 10-Q 07 Nov 2024 2025 Q2
Q2 2024 $1,703,000 -$450,800 -21% 30 Jun 2024 10-Q 13 Aug 2024 2025 Q1
Q1 2024 $1,820,000 -$440,000 -19% 31 Mar 2024 10-K 17 Jun 2025 2025 FY
Q4 2023 $1,933,600 -$430,500 -18% 31 Dec 2023 10-Q 13 Feb 2024 2024 Q3
Q3 2023 $2,045,000 -$420,700 -17% 30 Sep 2023 10-Q 09 Nov 2023 2024 Q2
Q2 2023 $2,153,800 -$411,200 -16% 30 Jun 2023 10-Q 10 Aug 2023 2024 Q1
Q1 2023 $2,260,000 -$402,000 -15% 31 Mar 2023 10-K 11 Jun 2024 2024 FY
Q4 2022 $2,364,100 -$392,700 -14% 31 Dec 2022 10-Q 07 Feb 2023 2022 Q3
Q3 2022 $2,465,700 -$563,400 -19% 30 Sep 2022 10-Q 10 Nov 2022 2022 Q2
Q2 2022 $2,565,000 -$560,300 -18% 30 Jun 2022 10-Q 11 Aug 2022 2022 Q1
Q1 2022 $2,662,000 -$557,600 -17% 31 Mar 2022 10-K 28 Jun 2023 2023 FY
Q4 2021 $2,756,800 -$555,300 -17% 31 Dec 2021 10-Q 10 Feb 2022 2022 Q3
Q3 2021 $3,029,100 -$373,900 -11% 30 Sep 2021 10-Q 10 Nov 2021 2022 Q2
Q2 2021 $3,125,300 -$366,800 -11% 30 Jun 2021 10-Q 12 Aug 2021 2021 Q1
Q1 2021 $3,219,600 -$360,000 -10% 31 Mar 2021 10-K 23 Jun 2022 2022 FY
Q4 2020 $3,312,100 -$353,500 -9.6% 31 Dec 2020 10-Q 11 Feb 2021 2021 Q3
Q3 2020 $3,403,000 -$347,200 -9.3% 30 Sep 2020 10-Q 12 Nov 2020 2021 Q2
Q2 2020 $3,492,100 -$341,200 -8.9% 30 Jun 2020 10-Q 13 Aug 2020 2021 Q1
Q1 2020 $3,579,600 +$3,579,600 31 Mar 2020 10-K 29 Jun 2021 2021 FY
Q4 2019 $3,665,600 31 Dec 2019 10-Q 13 Feb 2020 2020 Q3
Q3 2019 $3,750,200 30 Sep 2019 10-Q 07 Nov 2019 2020 Q2
Q2 2019 $3,833,300 30 Jun 2019 10-Q 13 Aug 2019 2020 Q1
Q1 2019 $0 31 Mar 2019 10-K 29 Jun 2020 2020 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.